Clinical meaning
Mumps is an acute, systemic viral infection caused by the mumps virus, a member of the Paramyxoviridae family and the genus Rubulavirus. The mumps virus is a single-stranded, negative-sense RNA virus with an envelope containing hemagglutinin-neuraminidase (HN) and fusion (F) glycoproteins that facilitate viral attachment to and entry into host cells. Transmission occurs through respiratory droplets (coughing, sneezing, talking) and direct contact with infected saliva. The virus is highly contagious, with a secondary attack rate of approximately 50-60% among susceptible household contacts. After inhalation, the mumps virus initially infects and replicates in the respiratory epithelium of the nasopharynx and regional lymph nodes. A primary viremia follows within 2-3 days, disseminating the virus through the bloodstream to target organs, including the salivary glands (particularly the parotid glands), central nervous system, pancreas, testes, ovaries, and other glandular tissues. A secondary viremia occurs 5-7 days later, amplifying viral dissemination and corresponding with the onset of clinical symptoms. The incubation period is 12-25 days (average 16-18 days), and patients are infectious from approximately 2 days before symptom onset until 5 days after parotid swelling appears. The hallmark clinical feature is parotitis (inflammation and swelling of the parotid glands), which occurs in 60-70% of symptomatic infections. The parotid glands are the largest salivary glands, located bilaterally in front of and below each ear. When inflamed, the parotid gland swells and pushes the earlobe upward and outward, producing the characteristic 'chipmunk cheek' appearance. Parotitis is initially unilateral in 25% of cases but becomes bilateral in approximately 75% within 1-5 days. The swelling is tender to palpation and worsened by chewing, swallowing, or consuming acidic foods and beverages that stimulate salivary flow. The opening of the Stensen duct (parotid duct) on the buccal mucosa opposite the second upper molar may appear erythematous and edematous. Approximately 20-40% of mumps infections are asymptomatic or present with nonspecific respiratory symptoms without recognizable parotitis. The most clinically significant complications of mumps include orchitis (testicular inflammation), which occurs in 15-30% of post-pubertal males and presents with severe testicular pain, swelling, and tenderness; it is usually unilateral and carries a small risk of testicular atrophy and subfertility but rarely causes complete sterility. Oophoritis (ovarian inflammation) occurs in approximately 5% of post-pubertal females and is generally milder than orchitis. Aseptic meningitis occurs in up to 10% of mumps cases and is usually self-limiting, while encephalitis is rare (less than 0.1%) but can cause permanent neurological sequelae. Pancreatitis occurs in approximately 4% of cases and may contribute to the development of type 1 diabetes in rare instances. Sensorineural hearing loss is the most common permanent complication, occurring in approximately 1 in 20,000 cases, and is usually unilateral. Prevention through the measles-mumps-rubella (MMR) vaccine is the primary public health strategy; two doses of MMR vaccine provide approximately 88% effectiveness against mumps. The practical nurse must recognize mumps presentations, implement appropriate droplet precautions, monitor for complications, and support patient comfort during the course of illness.